R
Richard P. Sloan
Researcher at Columbia University
Publications - 171
Citations - 11064
Richard P. Sloan is an academic researcher from Columbia University. The author has contributed to research in topics: Heart rate & Aerobic exercise. The author has an hindex of 47, co-authored 161 publications receiving 10061 citations. Previous affiliations of Richard P. Sloan include State University of New York System & Albert Einstein College of Medicine.
Papers
More filters
Journal ArticleDOI
An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus.
Ana C. Pereira,Daniel E. Huddleston,Adam M. Brickman,Alexander A. Sosunov,René Hen,Guy M. McKhann,Richard P. Sloan,Fred H. Gage,Truman R. Brown,Scott A. Small +9 more
TL;DR: MRI measurements of cerebral blood volume provide an imaging correlate of exercise-induced neurogenesis and that exercise differentially targets the dentate gyrus, a hippocampal subregion important for memory and implicated in cognitive aging are shown.
Journal ArticleDOI
Religion, spirituality, and medicine.
Journal ArticleDOI
Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease
Usman A. Khan,Li Liu,Frank A. Provenzano,Diego E. Berman,Caterina P. Profaci,Richard P. Sloan,Richard Mayeux,Karen Duff,Scott A. Small +8 more
TL;DR: The fMRI variant used to address basic questions about entorhinal cortex pathophysiology found that the LEC was affected in preclinical disease, that LEC dysfunction could spread to the parietal cortex duringPreclinical disease and that APP expression potentiated tau toxicity in driving L EC dysfunction, thereby helping to explain regional vulnerability in the disease.
Journal ArticleDOI
Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study.
TL;DR: Depression is an important independent risk factor for cardiac events after CABG surgery and did not predict deaths or admissions for non-cardiac events.
Journal ArticleDOI
Heart rate variability in depressive and anxiety disorders.
Jack M. Gorman,Richard P. Sloan +1 more
TL;DR: There is potential for the treatment of psychiatric disorders to affect positively the development and course of cardiovascular disease, and in patients with panic disorder, treatment with the selective serotonin reuptake inhibitor paroxetine normalizes heart rate variability.